1888 – 1971

Royal Raymond Rife

He built unusual microscopes and reported seeing filterable organisms that other researchers could not reproduce. Later accounts attributed disease-treatment claims to his frequency instruments. The Frequency Desk grades those claims against the surviving record. This guide is historical evaluation, not medical advice.

Open the Frequency DeskRead the Full Story

PRIMARY ARCHIVE

Evidence Vault

  • Smithsonian Annual Report (1944)
  • Congressional Record — Fitzgerald Report (1953)
  • San Diego Tribune & LA Times coverage (1931–1938)
  • Beam Ray trial transcripts (1939)
Explore sources

Universal Microscope

5,682 parts

Documented in 1944

Clinical Trial

Summer 1934

USC committee

Beam Ray

3–4.6 MHz

RF carrier

Surviving Unit

Microscope No. 5

Science Museum, London

SIGNATURE

The Frequency Desk

Place a common Rife claim on the bench — microscope, 1934 trial, Mortal Oscillatory Rates, suppression, modern FDA devices, or circulating lists. The readout shows how the story is told, what the record holds, and an evidence grade. No treatment frequencies. No device-building instructions.

HONEST VERDICT

Instruments existed. Extraordinary optical and clinical claims were not independently reproduced from an auditable file. Modern electromagnetic oncology devices do not validate consumer Rife machines.

Open the desk →

What the surviving record documents

Primary sources from the Smithsonian, Congressional Record, and contemporary newspapers.

Smithsonian • 1944

Universal Microscope

A 1944 publication reported the instrument's construction and Rife's extraordinary optical claims

San Diego Tribune • 1938

Front Page News

"Dread Disease Germs Killed by Radio Waves"

Congress • 1953

Fitzgerald Report

An investigator alleged obstruction of purported cancer treatments; the report did not validate Rife therapy

Science Museum • Present

Surviving Microscope

Microscope No. 5 preserved in London (Inv. 1990-667)

View all documentation and sources →

MODERN THERAPIES — IMPORTANTLY DISTINCT

FDA-authorized electromagnetic therapies show that electric fields can have specific biological effects. They do not validate Rife's microscope, MORs, frequency lists, or devices.

TTFields
Tumor Treating Fields

FDA-approved for glioblastoma. 100-300 kHz frequencies.

2024
TheraBionic HDE

FDA humanitarian exemption in 2023 for a narrow advanced-liver-cancer indication.

44%
Preprint Result

44% in-vitro leukemia-cell inhibition; not a clinical validation of Rife therapy.

The Frequency Desk

Grade microscope, trial, MOR, suppression, and modern-device claims against the record.

The Science

Microscope specs, Beam Ray technology, frequency data.

The Suppression

Legal events, missing records, and the interpretations built around them.

Resources

Books, archives, frequency databases, further reading.

FEATURED ARTICLE

The Night They Celebrated the End of Disease

On November 20, 1931, forty-four of America's most respected physicians gathered to honor a scientist who had achieved the impossible. Within eight years, almost every one of them would deny the dinner ever happened.

Read the full story →
"I have ended up a pauper, but I achieved the impossible."
— Royal Raymond Rife, 1960 affidavit